Clinical Trial
doi: 10.1111/j.1440-0960.1978.tb00195.x.
A double-blind controlled evaluation of diprosone cream 0.05% in comparison with synalar cream 0.01% in the treatment of psoriasis and other steroid responsive dermatoses
- PMID: 365166
- DOI: 10.1111/j.1440-0960.1978.tb00195.x
Item in Clipboard
Clinical Trial
A double-blind controlled evaluation of diprosone cream 0.05% in comparison with synalar cream 0.01% in the treatment of psoriasis and other steroid responsive dermatoses
Australas J Dermatol.
1978 Aug.
No abstract available
Similar articles
-
A double-blind controlled trial of betamethasone dipropionate 0.05% (Diproderm) in comparison with fluocinolone acetonide 0.025% (Synalar) in psoriasis and other steroid-responsive dermatoses.J Int Med Res. 1979;7(5):411-4. doi: 10.1177/030006057900700514. J Int Med Res. 1979. PMID: 387495 Clinical Trial.
-
Diprosone ointment in psoriasis. A double-blind trial.S Afr Med J. 1974 Oct 5;48(48):2030-2. S Afr Med J. 1974. PMID: 4612753 Clinical Trial. No abstract available.
-
Betamethasone dipropionate cream for the treatment of psoriasis. A collaborative evaluation.Arch Dermatol. 1976 May;112(5):681-3. Arch Dermatol. 1976. PMID: 776090 Clinical Trial.
-
An evaluation of betamethasone dipropionate (Diprosone) versus Locacorten 0.02% cream.Dermatologica. 1976;153(3):177-8. doi: 10.1159/000251113. Dermatologica. 1976. PMID: 797592 Clinical Trial.
-
Comparative double-blind clinical trial of fluocinonide and betamethasone valerate.Acta Derm Venereol Suppl (Stockh). 1971 May;52(67):70-1. Acta Derm Venereol Suppl (Stockh). 1971. PMID: 4947904 Clinical Trial. No abstract available.
Cited by
-
Strategies for using topical corticosteroids in children and adults with eczema.Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013356. doi: 10.1002/14651858.CD013356.pub2. Cochrane Database Syst Rev. 2022. PMID: 35275399 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
